A Cis-regulatory Site Downregulates PTHLH in Translocation T(8;12)(q13;p11.2) and Leads to Brachydactyly Type E
Overview
Molecular Biology
Authors
Affiliations
Parathyroid hormone-like hormone (PTHLH) is an important chondrogenic regulator; however, the gene has not been directly linked to human disease. We studied a family with autosomal-dominant Brachydactyly Type E (BDE) and identified a t(8;12)(q13;p11.2) translocation with breakpoints (BPs) upstream of PTHLH on chromosome 12p11.2 and a disrupted KCNB2 on 8q13. We sequenced the BPs and identified a highly conserved Activator protein 1 (AP-1) motif on 12p11.2, together with a C-ets-1 motif translocated from 8q13. AP-1 and C-ets-1 bound in vitro and in vivo at the derivative chromosome 8 breakpoint [der(8) BP], but were differently enriched between the wild-type and BP allele. We differentiated fibroblasts from BDE patients into chondrogenic cells and found that PTHLH and its targets, ADAMTS-7 and ADAMTS-12 were downregulated along with impaired chondrogenic differentiation. We next used human and murine chondrocytes and observed that the AP-1 motif stimulated, whereas der(8) BP or C-ets-1 decreased, PTHLH promoter activity. These results are the first to identify a cis-directed PTHLH downregulation as primary cause of human chondrodysplasia.
Sun J, Yang N, Xu Z, Cheng H, Zhang X Mol Genet Genomic Med. 2024; 12(2):e2393.
PMID: 38407575 PMC: 10844838. DOI: 10.1002/mgg3.2393.
Finsterer J J Family Med Prim Care. 2024; 12(12):3415-3417.
PMID: 38361886 PMC: 10866254. DOI: 10.4103/jfmpc.jfmpc_642_23.
ADAM19 cleaves the PTH receptor and associates with brachydactyly type E.
Aydin A, Klenk C, Nemec K, Isbilir A, Martin L, Zauber H Life Sci Alliance. 2024; 7(4).
PMID: 38331475 PMC: 10853454. DOI: 10.26508/lsa.202302400.
Scheffer-Rath M, Veenstra-Knol H, Boot A Bone Rep. 2023; 19:101699.
PMID: 37501674 PMC: 10368755. DOI: 10.1016/j.bonr.2023.101699.
Hong Y, Shan S, Gu Y, Huang H, Zhang Q, Han Y Nat Commun. 2022; 13(1):1309.
PMID: 35288560 PMC: 8921516. DOI: 10.1038/s41467-022-28903-7.